| Literature DB >> 31877023 |
Weijing Yang1,2, Fuwu Zhang2, Hongzhang Deng2, Lisen Lin2, Sheng Wang2, Fei Kang2, Guocan Yu2, Joseph Lau2, Rui Tian2, Mingru Zhang2, Zhantong Wang2, Liangcan He2, Ying Ma2, Gang Niu2, Shuo Hu1, Xiaoyuan Chen2.
Abstract
Combination therapy that could better balance immune activation and suppressive signals holds great potential in cancer immunotherapy. Herein, we serendipitously found that the pH-responsive nanovesicles (pRNVs) self-assembled from block copolymer polyethylene glycol-b-cationic polypeptide can not only serve as a nanocarrier but also cause immunogenic cell death (ICD) through preapoptotic exposure of calreticulin. After coencapsulation of a photosensitizer, 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) and an indoleamine 2,3-dioxygenase inhibitor, indoximod (IND), pRNVs/HPPH/IND at a single low dose elicited significant antitumor efficacy and abscopal effect following laser irradiation in a B16F10 melanoma tumor model. Treatment efficacy attributes to three key factors: (i) singlet oxygen generation by HPPH-mediated photodynamic therapy (PDT); (ii) increased dendritic cell (DC) recruitment and immune response provocation after ICD induced by pRNVs and PDT; and (iii) tumor microenvironment modulation by IND via enhancing P-S6K phosphorylation for CD8+ T cell development. This study exploited the nanocarrier to induce ICD for the host's immunity activation. The "all-in-one" smart nanovesicles allow the design of multifunctional materials to strengthen cancer immunotherapy efficacy.Entities:
Keywords: combination therapy; melanoma cancer immunotherapy; nanovesicle mediated immunogenic cell death; photodynamic therapy; tumor microenvironment modulation
Year: 2019 PMID: 31877023 DOI: 10.1021/acsnano.9b07212
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881